Trividia Health
Stage
Acquired | AcquiredValuation
$0000About Trividia Health
Trividia Health, fka Nipro Diagnostics, is a global health and wellness company and developer, manufacturer, and marketer of diabetes monitoring and management products. With products sold under TRUE and store brand labels, the company is the exclusive partner and supplier of affordable, high-quality blood glucose monitoring and health and wellness solutions for retail pharmacies, distributors, and mail service providers.
Trividia Health Headquarter Location
2400 N.W. 55th Court
Fort Lauderdale, Florida, 33309,
United States
954-677-9201
Expert Collections containing Trividia Health
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Trividia Health is included in 4 Expert Collections, including Diabetes.
Diabetes
1,750 items
Digital Health
13,075 items
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Medical Devices
3,088 items
Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)
Health Monitoring & Diagnostics
701 items
Companies developing technology to facilitate near-patient and point-of-care (POC) in vitro diagnostic testing. Companies tagged as #NearPatient&POCTesting
Trividia Health Patents
Trividia Health has filed 29 patents.
The 3 most popular patent topics include:
- Diabetes
- Blood tests
- Insulin therapies
Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
10/21/2019 | 5/10/2022 | Error detection and correction, Diabetes, Blood tests, Insulin therapies, Coding theory | Grant |
Application Date | 10/21/2019 |
---|---|
Grant Date | 5/10/2022 |
Title | |
Related Topics | Error detection and correction, Diabetes, Blood tests, Insulin therapies, Coding theory |
Status | Grant |
Latest Trividia Health News
Jun 29, 2022
News provided by Share this article Share this article The global point-of-care glucose testing market size is expected to reach USD 4.5 billion by 2030, growing at a CAGR of 4.1% over the forecast period. An increase in the demand for Point-of-Care Testing (POCT) has been witnessed in recent years. As compared to the conventional laboratory testing performed in central lab settings, glucose POCT aids in performing effective diagnosis at the patient's bedside. The easy and convenient operation of POCT has largely favored the growing usage of glucose meters across medical settings. The demand for performing bedside monitoring of blood sugar levels efficiently in a capillary blood sample and the need to ensure better management of carbohydrate metabolism have propelled the companies to launch innovative glucose meters in the market. Point-of-Care Glucose Testing Market Report Highlights Accu-Chek Inform II accounted for the largest revenue share in 2021 and is anticipated to maintain this trend throughout the forecast period. Bayer Contour blood glucose monitoring system is set to grow at a CAGR of 6.1% from 2022 to 2030. North America is the leading regional market due to the higher penetration of novel diagnostic techniques. Asia Pacific is estimated to register the fastest CAGR owing to the ever-increasing prevalence of diabetes and numerous untapped growth opportunities in diagnostics. Moreover, a robust network of local manufacturers has significantly contributed to the revenue generated in this region. Key Topics Covered: Chapter 2. Executive Summary 3.1. Market Lineage Outlook
Where is Trividia Health's headquarters?
Trividia Health's headquarters is located at 2400 N.W. 55th Court, Fort Lauderdale.
What is Trividia Health's latest funding round?
Trividia Health's latest funding round is Acquired.
Who are the investors of Trividia Health?
Investors of Trividia Health include Sinocare.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.